-
First-of-its-kind analysis reveals the structural variant landscape driving pediatric cancer development
03/12/2026
Learn how a first-of-its-kind dataset was helped identify the mutational processes that drive genomic structural changes specific to childhood disease.
-
Carsten Bönnemann, MD, joins St. Jude to expand research on pediatric catastrophic neurological disorders
03/12/2026
World-renowned clinician-scientist to chair, lead new department
-
Mapping 3D-super-enhancers with machine learning to pinpoint regulators of cell identity
03/09/2026
Discover how BOUQUET considers DNA’s 3D nature when identifying which enhancers, accompanying proteins and condensates are relevant to each gene’s expression.
-
Shared origins illuminate potential dependency across brain tumor types
03/05/2026
Explore new research findings showing how a set of rare brain tumors may arise from the same cell type, revealing a potential shared vulnerability to target.
-
Cell-free DNA offers early warning for bloodstream infections in kids with leukemia
03/02/2026
See how microbial cell-free DNA sequencing can predict bloodstream infections in children with leukemia days before symptoms appear
-
Differing immune responses in infants may explain increased severity of RSV over SARS-CoV-2
02/25/2026
Investigate research from St. Jude & The Jackson Labs explaining why infants get more severe disease from respiratory syncytial virus (RSV) than SARS-CoV-2.
-
Hearing loss contributes to cognitive decline after childhood cancer treatment
02/20/2026
See how radiation therapy causes sensorineural hearing loss in patients with emepdymoma which contributes to cognitive decline separate from chemotherapy.
-
James R. Downing, MD, to step down as president and CEO of St. Jude Children’s Research Hospital in late 2026
02/19/2026
Dr. Downing led St. Jude to unprecedented growth over the last 12 years.
-
Classifying pediatric brain tumors by liquid biopsy using artificial intelligence
02/17/2026
See how M-PACT, an AI-powered algorithm can sift through ctDNA in cerebrospinal fluid and molecularly classify tumors based on their DNA methylation pattern
-
Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents
01/15/2026
Dive into a St. Jude co-led clinical trial finding long-acting injectable HIV treatment is safe, effective & preferred by adolescents in multiple countries.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.